Trial reportResearch on child and adolescent psychopathology2026
Developmentally Tailored Telehealth-Delivered Cognitive-Behavioural Therapy for Adolescents with Body Dysmorphic Disorder: A Multiple Baseline Design.
Trial report in Research on child and adolescent psychopathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There is a paucity of research on the treatment of adolescent body dysmorphic disorder (BDD). Cognitive-behavioural therapy (CBT) has shown initial promise, yet many adolescents do not recover and face significant barriers in accessing treatment. The current study examined the acceptability and preliminary efficacy of developmentally tailored telehealth-delivered CBT for adolescents with BDD, using a single-case, nonconcurrent, multiple baseline design. Recruited from a broader study of correlates of BDD, 22 adolescents were eligible and were offered treatment. Sixteen (12 to 16 years; n = 5 boys) enrolled and were randomised to a one-, two- or three-week baseline period. Primary outcomes, assessed at post-treatment and again at 2-month follow-up, included BDD diagnostic status and symptom severity. Secondary outcomes included insight, functional impairment, comorbidity, anxiety, and depression. Acceptability and feasibility were examined by measuring participants’ treatment satisfaction, as well as examining drop-out rates. Seven participants dropped out of the study early, while 8 completed the 12-session treatment, and 1 completed 9 sessions. Among the treated sample, treatment satisfaction was high. BDD severity remained stable throughout the baseline and tended to improve following CBT. At post-treatment, 66.7% of the treated sample (37.5% of the total enrolled) participants were treatment responders, and 55.6% (31.3% enrolled) were still responders at 2-month follow-up. Significant reductions on most secondary outcomes were also observed. However, most participants remained symptomatic following treatment, and many dropped out early in treatment. Future studies are much needed to improve outcomes for adolescents with BDD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.